The association between gut hormones and diet-induced metabolic flexibility in metabolically healthy adults.
Journal
Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
11
08
2022
received:
12
05
2022
accepted:
15
08
2022
pmc-release:
01
01
2024
pubmed:
7
12
2022
medline:
23
12
2022
entrez:
6
12
2022
Statut:
ppublish
Résumé
This study investigated whether interindividual variance in diet-induced metabolic flexibility is explained by differences in gut hormone concentrations. A total of 69 healthy volunteers with normal glucose regulation underwent 24-hour assessments of respiratory quotient (RQ) in a whole-room indirect calorimeter during eucaloric feeding (EBL; 50% carbohydrate, 30% fat) and then, in a crossover design, during 24-hour fasting and three normal-protein (20%) overfeeding diets (200% energy requirements). Metabolic flexibility was defined as the change in 24-hour RQ from EBL during standard (50% carbohydrate), high-fat (60%), and high-carbohydrate (75%) overfeeding diets. Plasma concentrations of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) after an overnight fast were measured prior to and after each diet. Compared with EBL, on average, 24-hour RQ decreased by ~4% during high-fat overfeeding, whereas it increased by ~4% during standard overfeeding and by ~9% during high-carbohydrate overfeeding. During high-carbohydrate overfeeding, but not during any other overfeeding diet or fasting, increased GLP-1 concentration was associated with increased RQ (r = 0.44, p < 0.001), higher/lower carbohydrate/lipid oxidation rates (r = 0.34 and r = -0.51, both p < 0.01), respectively, and increased plasma insulin concentration (r = 0.38, p = 0.02). Increased GLP-1 concentration following high-carbohydrate overfeeding associated with a greater shift to carbohydrate oxidation, suggesting that GLP-1 may be implicated in diet-induced metabolic flexibility to carbohydrate overload.
Identifiants
pubmed: 36471908
doi: 10.1002/oby.23584
pmc: PMC9780166
mid: NIHMS1835207
doi:
Substances chimiques
Carbohydrates
0
Gastrointestinal Hormones
0
Glucagon-Like Peptide 1
89750-14-1
Insulin
0
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
139-149Subventions
Organisme : Intramural NIH HHS
ID : ZIA DK069029
Pays : United States
Informations de copyright
Published 2022. This article is a U.S. Government work and is in the public domain in the USA.
Références
Am J Physiol Regul Integr Comp Physiol. 2016 May 1;310(9):R866-74
pubmed: 26818056
Am J Physiol. 1990 Nov;259(5 Pt 1):E650-7
pubmed: 2240203
Am J Clin Nutr. 2006 Sep;84(3):556-60
pubmed: 16960169
Am J Clin Nutr. 1988 Apr;47(4):591-607
pubmed: 3281433
Int J Obes Relat Metab Disord. 2000 Mar;24(3):288-98
pubmed: 10757621
Endocrinology. 2006 Jan;147(1):3-8
pubmed: 16166213
Rev Endocr Metab Disord. 2014 Sep;15(3):181-7
pubmed: 24811133
Diabetes. 2004 Mar;53(3):654-62
pubmed: 14988249
Obesity (Silver Spring). 2006 Sep;14(9):1562-70
pubmed: 17030967
J Nutr. 2006 Jan;136(1):195-201
pubmed: 16365082
Endocr Rev. 2018 Aug 1;39(4):489-517
pubmed: 29697773
Endocrinology. 2010 Feb;151(2):569-75
pubmed: 19915164
Int J Obes (Lond). 2008 Dec;32 Suppl 7:S109-19
pubmed: 19136979
Metabolism. 2019 Jul;96:46-55
pubmed: 31029770
PLoS One. 2018 Jan 31;13(1):e0191609
pubmed: 29385178
Obesity (Silver Spring). 2017 May;25(5):873-880
pubmed: 28440048
Endocrinology. 2005 Dec;146(12):5120-7
pubmed: 16150917
Diabetes. 2020 Feb;69(2):181-192
pubmed: 31712321
Obesity (Silver Spring). 2020 Nov;28(11):2073-2077
pubmed: 32985108
Am J Physiol Endocrinol Metab. 2014 Jun 1;306(11):E1248-56
pubmed: 24735885
Diabetes. 2002 Dec;51 Suppl 3:S434-42
pubmed: 12475787
Int J Pediatr Endocrinol. 2009;2009:141753
pubmed: 19946401
J Physiol. 2009 Jan 15;587(1):19-25
pubmed: 19064614
Nutr Metab (Lond). 2016 Dec 9;13:92
pubmed: 27990172
Obesity (Silver Spring). 2019 May;27(5):691-699
pubmed: 31012296
Obesity (Silver Spring). 2020 Jun;28(6):1110-1116
pubmed: 32369268
Peptides. 1998;19(5):869-75
pubmed: 9663452
Cell Metab. 2017 May 2;25(5):1027-1036
pubmed: 28467922
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1009-17
pubmed: 18765680
Int J Obes Relat Metab Disord. 2001 Jun;25(6):781-92
pubmed: 11439290
Nature. 2002 Aug 8;418(6898):650-4
pubmed: 12167864
Diabetes Care. 2003 Jan;26 Suppl 1:S5-20
pubmed: 12502614
Int J Obes (Lond). 2017 Jun;41(6):887-893
pubmed: 28262678
Diabetologia. 1986 Jan;29(1):46-52
pubmed: 3514343
Diabetes Res Clin Pract. 2018 Aug;142:222-235
pubmed: 29857094
Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1062-8
pubmed: 17148749
Clin Sci (Lond). 1999 Apr;96(4):335-42
pubmed: 10087239
Obesity (Silver Spring). 2013 Aug;21(8):1602-7
pubmed: 23666746
Am J Physiol. 1988 Sep;255(3 Pt 1):E332-7
pubmed: 3421330
Diabetes. 2015 Nov;64(11):3680-9
pubmed: 26185280
Curr Obes Rep. 2018 Dec;7(4):276-288
pubmed: 30155850
Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E238-45
pubmed: 16940471
J Clin Endocrinol Metab. 2013 Jul;98(7):2791-9
pubmed: 23666976
J Clin Endocrinol Metab. 2013 May;98(5):E847-55
pubmed: 23509106